Accuracy of Noninvasive Scoring Systems in Assessing Risk of Death and Liver-Related Endpoints in Patients With Nonalcoholic Fatty Liver Disease
Hannes Hagström, Patrik Nasr, Mattias Ekstedt et al. · Clinical Gastroenterology and Hepatology · 2018
Cited by 132 works. doi:10.1016/j.cgh.2018.11.030
Authors
References
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
- Regression modelling strategies for improved prognostic prediction
- Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls
- External review and validation of the Swedish national inpatient register
- A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
- The NAFLD fibrosis score